Function
Processes
Locations
Nuclear sirtuin and the best-characterised NAD+-dependent deacetylase; deacetylates histones and many transcription factors and coregulators, including p53 at Lys382.
Besides serving as a hydride carrier in redox reactions, NAD+ is a substrate that is broken down by three classes of signalling enzymes. Each cleaves the bond between nicotinamide and ribose, releases free nicotinamide and uses the ADP-ribose moiety. The sirtuins (SIRT1-7) are NAD+-dependent protein deacylases. They transfer an acetyl group, or another acyl group such as succinyl, malonyl, glutaryl, lipoyl or a long-chain fatty acyl, from a protein lysine to the ADP-ribose of NAD+, producing nicotinamide and 2''-O-acyl-ADP-ribose. SIRT1, SIRT6 and SIRT7 act in the nucleus, SIRT2 mainly in the cytoplasm, and SIRT3, SIRT4 and SIRT5 in mitochondria. SIRT5 is chiefly a desuccinylase, demalonylase and deglutarylase, SIRT4 a lipoamidase, and SIRT4 and SIRT6 also mono-ADP-ribosylate proteins. The PARP (ARTD) family of ADP-ribosyltransferases transfers ADP-ribose from NAD+ to protein acceptor residues. PARP1, PARP2 and the tankyrases TNKS and TNKS2 build poly(ADP-ribose) chains; DNA-break-activated PARP1, with its cofactor HPF1, is the largest NAD+ consumer after genotoxic stress. Most other PARPs (PARP3, PARP4, PARP6, PARP8, PARP10-12, PARP14-16 and TIPARP/PARP7) attach a single ADP-ribose. The ectoenzymes CD38 and BST1 (CD157) are NAD+ glycohydrolases and ADP-ribosyl cyclases. They convert NAD+ mostly to ADP-ribose and partly to the calcium-mobilising messenger cyclic ADP-ribose, which they also hydrolyse. Protein ADP-ribosylation is reversed by PAR glycohydrolase (PARG), which cleaves PAR chains, and by the macrodomain hydrolases MACROD1, MACROD2 and OARD1 (TARG1), which remove the last ADP-ribose from glutamate and aspartate residues. The nicotinamide released by all of these reactions is recycled to NAD+ by the NAMPT salvage pathway. Because the consumers share a limited NAD+ pool, strong PARP1 or CD38 activity lowers NAD+ and with it sirtuin activity, coupling DNA damage, inflammation and ageing to metabolic signalling.
Derived from the RGD Pathway Ontology record and diagram PW:0002581 (nicotinamide adenine nucleotide utilization pathway) through the RGD_PATHWAY_ONTOLOGY project's diagram->module route; curated GO mapping GO:0019677 NAD+ catabolic process (skos:closeMatch). The RGD diagram supplies the boundary (NAD+ in; target deacetylation, target ribosylation, cyclic ADP-ribose and target deribosylation out) and the 33-gene human set. It is modelled as two required parts and one optional part: (1) a variant set of the three NAD+-consuming enzyme classes, sirtuins, PARP/ARTD ADP-ribosyltransferases (split into poly- and mono-ADP-ribosylation) and the CD38/BST1 NAD+ glycohydrolases/ADP-ribosyl cyclases; (2) the hydrolytic reversal of protein ADP-ribosylation by PARG and the macrodomain hydrolases; and (3) an optional module_ref to the NAMPT/NMN realization of modules/nad_biosynthesis_salvage.yaml, which recycles the released nicotinamide. The three RGD subpathway terms drawn as diagram nodes (PW:0002582, PW:0002583, PW:0002584) are listed as evidence because the variants cover them. The fourth diagram link, PW:0000219 NAD+ biosynthetic pathway, is not: NAD+ synthesis is modelled in modules/nad_biosynthesis_salvage.yaml and modules/kynurenine_nad_de_novo.yaml and is only referenced here. Boundary decisions. (a) PAR readers APLF, CHFR and RNF146 are context, not participants. Each binds poly(ADP-ribose) (GO:0072572, IDA; PMID:18172500, PMID:21478859), but none consumes NAD+ or transfers or removes ADP-ribose. Their own activities (APLF histone chaperone and nuclease, CHFR and RNF146 ubiquitin ligase) act downstream in DNA repair, mitotic checkpoint control and tankyrase-directed proteolysis of AXIN. RGD itself draws the readers only as associated with target ribosylation. (b) ZC3HAV1 (PARP13, ZAP) is excluded. Its reviewed UniProt entry Q7Z2W4 states that its divergent PARP-homology domain lacks the structural requirements for NAD+ binding and is inactive. QuickGO (checked 2026-10-28) records NOT NAD+-protein mono-ADP-ribosyltransferase activity (IDA, PMID:25043379), NOT NAD+ poly-ADP-ribosyltransferase activity and NOT NAD+ binding (IMP, PMID:25635049). Its antiviral RNA-binding role is unrelated to NAD+ consumption. (c) PARP9 is in neither the RGD gene list nor the participant set, and its catalytic status is disputed. QuickGO carries both NOT GO:0003950 and NOT NAD+ binding (IMP, PMID:16061477) and positive GO:0140802 C-terminal glycine ADP-ribosyltransferase (IDA, PMID:28525742, ubiquitin ADP-ribosylation by the DTX3L-PARP9 heterodimer) and GO:0003950 (IDA, PMID:23230272). PMID:27796300 found that PARP9 does not ADP-ribosylate STAT1 and instead suppresses PARP14. This is recorded as a knowledge gap. (d) GO usage of GO:0019677. In human GOA the term is carried only by NAD+-degrading enzymes: SARM1 (IDA, many papers), NUDT12 (IDA), NUDT17 (IBA), plus IEA rows on NNMT and PARP14 (GO_REF:0000107). No sirtuin or PARP carries it, because GO describes their process as protein deacylation or ADP-ribosylation, with NAD+ as cosubstrate. GO:0019677 is therefore kept as the module-level concept (the closeMatch) and is not put on the sirtuin or PARP annotons. It is put on the CD38 and BST1 annotons, because their NAD+ glycohydrolase chemistry (NAD+ to ADP-ribose or cADPR plus nicotinamide) is the same as that of SARM1, whose GO:0019677 annotation rests on IDA. Neither CD38 nor BST1 carries GO:0019677 in GOA; this is a possible curation gap, not asserted here as a GOA annotation. The PARP14 IEA row looks like an over-propagated orthology transfer and is a candidate for upstream review. (e) Molecular functions come from each protein's experimental GO annotations in QuickGO (checked 2026-10-28), cross-checked against the Rhea xrefs of the GO terms and the cached abstracts: SIRT1, SIRT2, SIRT3, SIRT6 and SIRT7 GO:0034979 (EXP/IDA; RHEA:43636); SIRT5 GO:0036055 (IDA; RHEA:47668; demalonylase GO:0036054 and deglutarylase GO:0061697 in prose); SIRT4 GO:0106419 (EXP/IDA; RHEA:63640) and GO:0140803 (EXP; RHEA:56612); SIRT6 GO:0140804 (EXP; RHEA:58220); PARP1 GO:0140805 (EXP/IDA; RHEA:58232) and GO:0003950 (EXP/IDA); PARP2, TNKS and TNKS2 GO:0003950 (IDA/EXP); PARP3, PARP4, PARP8, PARP11, PARP12, PARP15 and TIPARP GO:1990404 (IDA); PARP6 GO:0140803 (IDA); PARP10, PARP14 and PARP16 GO:0140807 (EXP/IDA; RHEA:58224); CD38 and BST1 GO:0061809 (EXP/IDA; RHEA:38611, RHEA:38615, plus NAD+ hydrolysis RHEA:16301); PARG GO:0004649 (EXP/IDA; RHEA:52216); MACROD1, MACROD2 and OARD1 GO:0140293 (IDA; RHEA:58248). PAR chain elongation (EC 2.4.2.30) has no Rhea reaction, so the PAR annotons carry the EC equation in prose. Most PARP mono-ARTs (PARP3, PARP4, PARP6, PARP8, PARP10, PARP11, PARP12, PARP14, PARP15, PARP16, TIPARP) also carry GO:0003950 poly-ADP-ribosyltransferase activity in GOA, by IBA and in some cases IDA/IMP. That conflicts with the family-wide product assignment (PMID:25043379), which found that most PARPs make MAR, and with the substrate-assisted mechanism that prevents PARP10-type enzymes from polymerising (PMID:18851833). These rows are candidates for IBA and upstream review, and GO:0003950 is not used for them here. Also not adopted: SIRT7 protein methyltransferase activity (GO:0008276, IDA; also an activity in GO-CAM gomodel:63c0ac2b00001853). It is unexpected for a sirtuin and is flagged for review. (f) Outside the RGD gene list and the module: the serine-ADP-ribose hydrolase ADPRS (ARH3), which removes the HPF1-dependent serine mono-ADP-ribose that PARG leaves; the NUDIX ADP-ribose pyrophosphatases (NUDT5, NUDT9) that clear free ADP-ribose; the NAD+ hydrolase SARM1; the ecto-ARTs ART1-5; and NNMT, which methylates the nicotinamide product. The ADPRS omission means the reversal part as drawn by RGD is incomplete for serine-linked marks. The PARP1 cofactor HPF1 is described in the PARP1 annoton but is not a participant. Downstream signalling by cADPR (ryanodine receptors) and NAADP (two-pore channels) is out of scope. (g) GO-CAM: gocams/index.tsv (checked 2026-10-28) has production models for 12 of the 33 genes. The project's best-overlap model gomodel:627d95ee00002067 is linked at module level and on the PARP1 and PARP2 annotons, and further models are linked on the SIRT1, SIRT2, SIRT3, SIRT6, SIRT7, PARP1, PARP2, PARP12 and PARP16 annotons. Possible GO-CAM issue: in gomodel:696022cd00000603 (Regulation of the TCA cycle by SIRT3) the SIRT3 deacetylase activity is part of GO:0008053 mitochondrial fusion, which does not match the model title. Gene reviews exist for PARP1, SIRT1, SIRT2, SIRT5 and TNKS; the other members have none. Publications cited are abstract-only in the cache except PMID:22076378, PMID:25525879, PMID:27568560, PMID:28190768, PMID:23481255, PMID:23275542, PMID:27796300, PMID:30104678 and PMID:34314702.
knowledge_gaps[0].provenance[0] · reference_section_type
(0/1)knowledge_gaps[0].provenance[1] · reference_section_type
(0/1)knowledge_gaps[1].provenance[0] · reference_section_type
(0/1)✗ none found
No MODULE:nad_consumption deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
6 gene-function check(s) reflected in core functions · 0 conflict(s) · 25 evidence or coverage gap(s) (31 comparison(s))
Retained noncore functions are reported separately; they do not require promotion to core functions. Support from representative genes does not establish conservation across the whole family. Missing reviews or identifiers leave a claim unverified.
| Annoton | Participant | Function | Assessment |
|---|---|---|---|
| sirt1_deacetylase | SIRT1 UniProtKB:Q96EB6 Gene |
NAD-dependent protein lysine deacetylase activity GO:0034979 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| sirt2_deacetylase | SIRT2 UniProtKB:Q8IXJ6 Gene |
NAD-dependent protein lysine deacetylase activity GO:0034979 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| sirt3_deacetylase | SIRT3 UniProtKB:Q9NTG7 Gene |
NAD-dependent protein lysine deacetylase activity GO:0034979 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| sirt6_deacetylase | SIRT6 UniProtKB:Q8N6T7 Gene |
NAD-dependent protein lysine deacetylase activity GO:0034979 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| sirt7_deacetylase | SIRT7 UniProtKB:Q9NRC8 Gene |
NAD-dependent protein lysine deacetylase activity GO:0034979 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| sirt5_desuccinylase | SIRT5 UniProtKB:Q9NXA8 Gene |
protein-succinyllysine desuccinylase activity GO:0036055 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| sirt4_lipoamidase | SIRT4 UniProtKB:Q9Y6E7 Gene |
NAD-dependent protein lipoamidase activity GO:0106419 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| sirt6_mart | SIRT6 UniProtKB:Q8N6T7 Gene |
NAD+-protein-lysine ADP-ribosyltransferase activity GO:0140804 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| sirt4_mart | SIRT4 UniProtKB:Q9Y6E7 Gene |
NAD+-protein-cysteine ADP-ribosyltransferase activity GO:0140803 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp1_ser_initiation | PARP1 UniProtKB:P09874 Gene |
NAD+-protein-serine ADP-ribosyltransferase activity GO:0140805 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| parp1_par | PARP1 UniProtKB:P09874 Gene |
NAD+ poly-ADP-ribosyltransferase activity GO:0003950 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| parp2_par | PARP2 UniProtKB:Q9UGN5 Gene |
NAD+ poly-ADP-ribosyltransferase activity GO:0003950 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| tnks_par | TNKS UniProtKB:O95271 Gene |
NAD+ poly-ADP-ribosyltransferase activity GO:0003950 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| tnks2_par | TNKS2 UniProtKB:Q9H2K2 Gene |
NAD+ poly-ADP-ribosyltransferase activity GO:0003950 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp3_mart | PARP3 UniProtKB:Q9Y6F1 Gene |
NAD+-protein mono-ADP-ribosyltransferase activity GO:1990404 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp4_mart | PARP4 UniProtKB:Q9UKK3 Gene |
NAD+-protein mono-ADP-ribosyltransferase activity GO:1990404 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp6_mart | PARP6 UniProtKB:Q2NL67 Gene |
NAD+-protein-cysteine ADP-ribosyltransferase activity GO:0140803 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp8_mart | PARP8 UniProtKB:Q8N3A8 Gene |
NAD+-protein mono-ADP-ribosyltransferase activity GO:1990404 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp10_mart | PARP10 UniProtKB:Q53GL7 Gene |
NAD+-protein-glutamate ADP-ribosyltransferase activity GO:0140807 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp11_mart | PARP11 UniProtKB:Q9NR21 Gene |
NAD+-protein mono-ADP-ribosyltransferase activity GO:1990404 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp12_mart | PARP12 UniProtKB:Q9H0J9 Gene |
NAD+-protein mono-ADP-ribosyltransferase activity GO:1990404 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp14_mart | PARP14 UniProtKB:Q460N5 Gene |
NAD+-protein-glutamate ADP-ribosyltransferase activity GO:0140807 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp15_mart | PARP15 UniProtKB:Q460N3 Gene |
NAD+-protein mono-ADP-ribosyltransferase activity GO:1990404 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parp16_mart | PARP16 UniProtKB:Q8N5Y8 Gene |
NAD+-protein-glutamate ADP-ribosyltransferase activity GO:0140807 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| tiparp_mart | TIPARP UniProtKB:Q7Z3E1 Gene |
NAD+-protein mono-ADP-ribosyltransferase activity GO:1990404 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| cd38_cyclase | CD38 UniProtKB:P28907 Gene |
NAD+ nucleosidase activity, cyclic ADP-ribose generating GO:0061809 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| bst1_cyclase | BST1 UniProtKB:Q10588 Gene |
NAD+ nucleosidase activity, cyclic ADP-ribose generating GO:0061809 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| parg_glycohydrolase | PARG UniProtKB:Q86W56 Gene |
poly(ADP-ribose) glycohydrolase activity GO:0004649 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| macrod1_hydrolase | MACROD1 UniProtKB:Q9BQ69 Gene |
ADP-ribosylglutamate-[protein] hydrolase activity GO:0140293 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| macrod2_hydrolase | MACROD2 UniProtKB:A1Z1Q3 Gene |
ADP-ribosylglutamate-[protein] hydrolase activity GO:0140293 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
| oard1_hydrolase | OARD1 UniProtKB:Q9Y530 Gene |
ADP-ribosylglutamate-[protein] hydrolase activity GO:0140293 |
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked. |
3 complete review(s) · 4 with deep research · 23 missing review · 1 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| MACROD2 A1Z1Q3 | ✗ | — | — |
| CD38 P28907 | ✗ | — | — |
| PARP1 P09874 | ✓ | ✓ | ✗ |
| BST1 Q10588 | ✗ | — | — |
| PARP6 Q2NL67 | ✗ | — | — |
| PARP15 Q460N3 | ✗ | — | — |
| PARP14 Q460N5 | ✗ | — | — |
| PARP10 Q53GL7 | ✗ | — | — |
| TIPARP Q7Z3E1 | ✗ | — | — |
| PARG Q86W56 | ✗ | — | — |
| PARP8 Q8N3A8 | ✗ | — | — |
| PARP16 Q8N5Y8 | ✗ | — | — |
| SIRT6 Q8N6T7 | ✗ | — | — |
| MACROD1 Q9BQ69 | ✗ | — | — |
| PARP12 Q9H0J9 | ✗ | — | — |
| TNKS2 Q9H2K2 | ✗ | — | — |
| PARP11 Q9NR21 | ✗ | — | — |
| SIRT7 Q9NRC8 | ✗ | — | — |
| SIRT3 Q9NTG7 | ✗ | — | — |
| PARP2 Q9UGN5 | ✗ | — | — |
| PARP4 Q9UKK3 | ✗ | — | — |
| OARD1 Q9Y530 | ✗ | — | — |
| SIRT4 Q9Y6E7 | ✗ | — | — |
| PARP3 Q9Y6F1 | ✗ | — | — |
| SIRT1 Q96EB6 | ✓ | 364/380 | ✓ |
| SIRT2 Q8IXJ6 | ✓ | 188/193 | ✓ |
| SIRT5 Q9NXA8 | ✓ | ✓ | ✓ |
| TNKS O95271 | ✓ | ✓ | ✓ |
Sirtuins, PARP-family ADP-ribosyltransferases and the CD38/BST1 NAD+ glycohydrolases each cleave NAD+ and release nicotinamide; the protein ADP-ribosylation made by PARPs is reversed by PARG and the macrodomain hydrolases, and the nicotinamide is salvaged to NAD+ by NAMPT.
Three enzyme classes use NAD+ as a substrate rather than as a redox cofactor. Each cleaves the nicotinamide-ribosyl bond, releases nicotinamide and destroys the NAD+ molecule.
Class III protein deacylases (sirtuins 1-7) share a conserved NAD+-binding catalytic core. They cleave the nicotinamide-ribosyl bond of NAD+ and transfer the protein acyl group to the ADP-ribose, so every deacylation consumes one NAD+ and yields nicotinamide and 2''-O-acyl-ADP-ribose. Nicotinamide is a non-competitive feedback inhibitor, which makes sirtuin activity sensitive to the NAD+/nicotinamide ratio.
Removal of an acetyl group from a protein lysine with NAD+ as cosubstrate. The ADP-ribose of NAD+ accepts the acetyl group, so each deacetylation consumes one NAD+ and releases nicotinamide and 2''-O-acetyl-ADP-ribose.
Nuclear sirtuin and the best-characterised NAD+-dependent deacetylase; deacetylates histones and many transcription factors and coregulators, including p53 at Lys382.
Predominantly cytoplasmic sirtuin that deacetylates alpha-tubulin and, at the G2/M transition, histone H4K16; it also removes long-chain fatty acyl groups (demyristoylase/depalmitoylase activity, retained in the SIRT2 gene review).
Major deacetylase of the mitochondrial matrix; activates glutamate dehydrogenase, isocitrate dehydrogenase 2 and other metabolic enzymes by deacetylation.
Chromatin-bound sirtuin that deacetylates histone H3K9, H3K18 and H3K56 and non-histone targets, and removes long-chain fatty acyl groups; its separate mono-ADP-ribosyltransferase activity is a variant below.
Nucleolar sirtuin; deacetylates H3K18 and the RNA polymerase I subunit PAF53, coupling rDNA transcription to stress. SIRT7 also carries desuccinylase and deglutarylase annotations (IDA).
Some sirtuins prefer acyl groups other than acetyl. The chemistry is the same: the acyl group is transferred to the ADP-ribose of NAD+, giving nicotinamide and 2''-O-acyl-ADP-ribose.
Mitochondrial sirtuin with weak deacetylase but efficient desuccinylase, demalonylase and deglutarylase activity, set by Tyr102 and Arg105 in its acyl pocket.
Mitochondrial sirtuin with no detectable deacetylase activity (NOT GO:0034979, IDA) that removes lipoyl groups from the DLAT E2 subunit of the pyruvate dehydrogenase complex, lowering PDH activity.
SIRT4 and SIRT6 also transfer the whole ADP-ribose of NAD+ to a protein acceptor, releasing nicotinamide. The physiological weight of this activity, relative to their deacylase activities, is less certain than for the PARPs.
Under oxidative stress SIRT6 mono-ADP-ribosylates PARP1 on Lys521, stimulating PARP1 poly-ADP-ribosylation at DNA double-strand breaks.
SIRT4 ADP-ribosylates glutamate dehydrogenase and model acceptors, inhibiting GDH; the cysteine acceptor follows the GOA EXP annotation from the same study.
Diphtheria-toxin-like ADP-ribosyltransferases (the PARP/ARTD family) cleave NAD+ and transfer its ADP-ribose to a protein acceptor (or to DNA ends), releasing nicotinamide. They divide by product into poly-ADP-ribose polymerases and mono-ADP-ribosyltransferases.
The few PARPs that keep the catalytic glutamate of the H-Y-E triad build ADP-ribose chains of up to about 200 units on an initiating ADP-ribose, consuming one NAD+ per unit.
At DNA breaks, PARP1 bound to its cofactor HPF1 attaches the first ADP-ribose to serine residues of histones and of PARP1 itself; this is the main initiation site of DNA damage-induced ADP-ribosylation.
DNA-break-activated PARP1 elongates and branches poly(ADP-ribose) chains; at maximal activation it can deplete cellular NAD+ by most of its pool, which is the basis of PARP1-SIRT1 competition for NAD+.
DNA-damage-activated PARP2 is stimulated by PARP1-made PAR and synthesises branched chains; with HPF1 it also initiates on serine (GO:0140805, IDA).
Ankyrin-repeat PARP that poly-ADP-ribosylates TRF1, AXIN and itself; the PAR it adds is read by RNF146 and directs targets to proteasomal degradation.
Tankyrase-1 paralogue with the same substrate range and partial redundancy.
Most PARPs lack the catalytic glutamate and transfer a single ADP-ribose to an acceptor residue (glutamate, aspartate, cysteine, lysine or serine), consuming one NAD+ per modification.
DNA-break-associated mono-ADP-ribosyltransferase that modifies histone H1 and itself and, with PARP1, acts in double-strand break repair.
Vault-associated PARP (VPARP); mono-ADP-ribosyltransferase activity shown in the family-wide assay (IDA). Its physiological substrates are poorly defined.
Mono-ADP-ribosylates cysteine (and aspartate) residues in the family-wide automodification assay (IDA).
PARP6 paralogue; mono-ADP-ribosyltransferase activity with cysteine acceptors (GO:0140803, EXP).
Prototype mono-ART of the family: lacking the catalytic glutamate, it uses substrate-assisted catalysis to mono-ADP-ribosylate acidic residues (for example of GSK3B), a modification reversed by MACROD1, MACROD2 and OARD1.
Mono-ADP-ribosyltransferase with glutamate, aspartate, lysine and cysteine acceptors in the family-wide assay (EXP).
Interferon-induced mono-ART; at the trans-Golgi network it mono-ADP-ribosylates GOLGA1 to support E-cadherin transport.
Macrodomain-containing mono-ART that mono-ADP-ribosylates STAT1 on Glu657 and Glu705 and regulates macrophage activation; PARP9 suppresses this activity.
Macrodomain-containing PARP14 paralogue; mono-ADP-ribosyltransferase activity in the family-wide assay (IDA).
Tail-anchored ER-membrane mono-ART that modifies ribosomal proteins on glutamate/aspartate, limiting translation; it draws on cytosolic NAD+ made by NMNAT2.
PARP7; aryl hydrocarbon receptor target gene whose mono-ART activity represses AHR transactivation in a negative feedback loop.
The ectoenzymes CD38 and BST1 (CD157) cleave NAD+ to nicotinamide and either cyclise the ADP-ribose to cyclic ADP-ribose (cADPR) or, far more often, hydrolyse it to ADP-ribose; they also hydrolyse cADPR to ADP-ribose. CD38 hydrolyses roughly 100 NAD+ for each cADPR made and is a dominant NAD+ consumer in many mammalian tissues. cADPR acts as a calcium-mobilising messenger at ryanodine receptors.
Type II transmembrane glycoprotein of leukocytes and many other cells whose C-terminal catalytic domain usually faces outward, though catalytically active intracellular forms exist. It makes cADPR and ADP-ribose and hydrolyses cADPR; under acidic conditions it can also make NAADP (not modelled).
GPI-anchored CD38 paralogue of bone marrow stromal and myeloid cells, with ADP-ribosyl cyclase and cADPR hydrolase activity; its catalytic efficiency is much lower than that of CD38.
ADP-ribosylation is reversible. PAR glycohydrolase (PARG) hydrolyses the ribose-ribose bonds of poly(ADP-ribose), releasing free ADP-ribose, but cannot remove the proximal ADP-ribose attached to the protein. The macrodomain hydrolases MACROD1, MACROD2 and OARD1 (TARG1) remove mono-ADP-ribose from glutamate and aspartate residues, again releasing ADP-ribose. ADP-ribose made here and by CD38/BST1 is cleaved further by NUDIX hydrolases, outside this module.
The only enzyme that hydrolyses PAR chains efficiently, by exo- and endoglycosidic cleavage; it turns over PAR made by PARP1 and PARP2 within minutes of DNA damage.
Mitochondrially enriched macrodomain hydrolase that removes mono-ADP-ribose from acidic residues; it also deacetylates O-acetyl-ADP-ribose (GO:0019213, IDA).
MACROD1 paralogue; reverses PARP10 mono-ADP-ribosylation of GSK3B, restoring kinase activity.
Terminal ADP-ribose protein glycohydrolase that removes the protein-proximal ADP-ribose left by PARG on glutamate residues; its loss causes neurodegeneration in humans. It also deacetylates O-acetyl-ADP-ribose (GO:0061463, IDA).
Included by reference to the NAMPT/NMN realization of the NAD+ biosynthesis and salvage module: nicotinamide released by every consumer above is phosphoribosylated by NAMPT to NMN and adenylylated by NMNAT to NAD+, closing the cycle.
Realized by module
nad_biosynthesis_salvage#nmn_to_nad_realization